Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.7000 (-1.27%) ($23.7000 - $23.7000) on Wed. Sep. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.07% (three month average) | RSI | 70 | Latest Price | $23.7000(-1.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) XBI(41%) IWO(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.535% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) IGOV(-8%) TBT(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.535% (StdDev 3.07%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $24.31(-2.51%) | 10 Day Moving Average | $23.95(-1.04%) | 20 Day Moving Average | $22.86(3.67%) | To recent high | -12.2% | To recent low | 15.5% | Market Cap | $3.471b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |